Rationale: Allosensitization may be a barrier to lung transplant. Currently, consideration is not given to allosensitization when assigning priority on the lung transplant waiting list. Objectives: We aimed to examine the association between allosensitization and waiting list outcomes. Methods: We conducted a retrospective single-center cohort study of adults listed for lung transplant at our center between January 1, 2006, and December 31, 2016. We screened candidates for human leukocyte antigen antibodies before listing and examined the association between allosensitization and waiting list outcomes, including likelihood of transplant and death on the waiting list, using a competing risk model. Calculated panel-reactive antibody (CPRA) was used as a continuous measure of allosensitization. Results: Among 746 candidates who were listed for lung transplant during the study period, 263 (35%) were allosensitized, and 483 (65%) were not. In unadjusted analysis, allosensitized candidates had a decreased likelihood of transplant compared with nonallosensitized candidates (subhazard ratio [sHR], 0.71; 95% confidence interval [CI], 0.60-0.83; P < 0.001) and were more likely to die on the waiting list (sHR, 1.66; 95% CI, 1.08-2.58; P < 0.001). In multivariable modeling, increasing CPRA was associated with an increased risk of death and a decreased likelihood of transplant (sHR for death, 1.15 per 10% increase in CPRA; 95% CI, 1.07-1.22; P < 0.001; sHR for transplant, 0.89 per 10% increase in CPRA; 95% CI, 0.86-0.91; P < 0.001). Conclusions: Broad allosensitization was associated with longer waiting times, decreased likelihood of transplant, and increased risk of death among candidates on the waiting list for lung transplant. Consideration of allosensitization in organ allocation strategies might help mitigate this increased risk in highly allosensitized candidates.
Rationale: Allosensitization may be a barrier to lung transplant. Currently, consideration is not given to allosensitization when assigning priority on the lung transplant waiting list. Objectives: We aimed to examine the association between allosensitization and waiting list outcomes. Methods: We conducted a retrospective single-center cohort study of adults listed for lung transplant at our center between January 1, 2006, and December 31, 2016. We screened candidates for human leukocyte antigen antibodies before listing and examined the association between allosensitization and waiting list outcomes, including likelihood of transplant and death on the waiting list, using a competing risk model. Calculated panel-reactive antibody (CPRA) was used as a continuous measure of allosensitization. Results: Among 746 candidates who were listed for lung transplant during the study period, 263 (35%) were allosensitized, and 483 (65%) were not. In unadjusted analysis, allosensitized candidates had a decreased likelihood of transplant compared with nonallosensitized candidates (subhazard ratio [sHR], 0.71; 95% confidence interval [CI], 0.60-0.83; P < 0.001) and were more likely to die on the waiting list (sHR, 1.66; 95% CI, 1.08-2.58; P < 0.001). In multivariable modeling, increasing CPRA was associated with an increased risk of death and a decreased likelihood of transplant (sHR for death, 1.15 per 10% increase in CPRA; 95% CI, 1.07-1.22; P < 0.001; sHR for transplant, 0.89 per 10% increase in CPRA; 95% CI, 0.86-0.91; P < 0.001). Conclusions: Broad allosensitization was associated with longer waiting times, decreased likelihood of transplant, and increased risk of death among candidates on the waiting list for lung transplant. Consideration of allosensitization in organ allocation strategies might help mitigate this increased risk in highly allosensitized candidates.
Entities:
Keywords:
allosensitization; lung transplantation; organ allocation
Authors: C L Lau; S M Palmer; K E Posther; D N Howell; N L Reinsmoen; H T Massey; V F Tapson; J J Jaggers; T A D'Amico; R D Davis Journal: Ann Thorac Surg Date: 2000-05 Impact factor: 4.330
Authors: James P Bosanquet; Chad A Witt; Bradford C Bemiss; Derek E Byers; Roger D Yusen; Alexander G Patterson; Daniel Kreisel; Thalachallour Mohanakumar; Elbert P Trulock; Ramsey R Hachem Journal: J Heart Lung Transplant Date: 2015-06-10 Impact factor: 10.247
Authors: Keith M Wille; Kathy F Harrington; Joao A deAndrade; Sonia Vishin; Robert A Oster; Richard A Kaslow Journal: J Heart Lung Transplant Date: 2013-04-09 Impact factor: 10.247
Authors: E F Reed; P Rao; Z Zhang; H Gebel; R A Bray; I Guleria; J Lunz; T Mohanakumar; P Nickerson; A R Tambur; A Zeevi; P S Heeger; D Gjertson Journal: Am J Transplant Date: 2013-06-13 Impact factor: 8.086
Authors: Deborah J Levine; Allan R Glanville; Christina Aboyoun; John Belperio; Christian Benden; Gerald J Berry; Ramsey Hachem; Don Hayes; Desley Neil; Nancy L Reinsmoen; Laurie D Snyder; Stuart Sweet; Dolly Tyan; Geert Verleden; Glen Westall; Roger D Yusen; Martin Zamora; Adriana Zeevi Journal: J Heart Lung Transplant Date: 2016-02-10 Impact factor: 10.247
Authors: L D Snyder; A L Gray; J M Reynolds; G M Arepally; A Bedoya; M G Hartwig; R D Davis; K E Lopes; W E Wegner; D F Chen; S M Palmer Journal: Am J Transplant Date: 2014-02-19 Impact factor: 8.086
Authors: Jessica L Sell; Matthew Bacchetta; Samuel B Goldfarb; Hanyoung Park; Priscilla V Heffernan; Hilary A Robbins; Lori Shah; Kashif Raza; Frank D'Ovidio; Joshua R Sonett; Selim M Arcasoy; David J Lederer Journal: Am J Respir Crit Care Med Date: 2016-03-15 Impact factor: 21.405
Authors: Brian Feingold; Pam Bowman; Adriana Zeevi; Alin L Girnita; Eric S Quivers; Susan A Miller; Steven A Webber Journal: J Heart Lung Transplant Date: 2007-06 Impact factor: 10.247
Authors: Andrew M Courtwright; Severine Cao; Isabelle Wood; Hari R Mallidi; Jared Kawasawa; Anna Moniodis; Julie Ng; Souheil El-Chemaly; Hilary J Goldberg Journal: Ann Am Thorac Soc Date: 2019-09
Authors: Yaron D Barac; Mike S Mulvihill; Oliver Jawitz; Jacob Klapper; John Haney; Mani Daneshmand; Basil Nasir; Dongfeng Chen; Carmelo A Milano; Matthew G Hartwig Journal: Ann Thorac Surg Date: 2020-04-03 Impact factor: 4.330
Authors: Joshua A Rushakoff; Loren Gragert; Marcelo J Pando; Darren Stewart; Edmund Huang; Irene Kim; Stanley Jordan; Kelsi Lindblad; Xiaohai Zhang; Peter Lalli; Jignesh K Patel; Jon A Kobashigawa; Evan P Kransdorf Journal: Transplant Direct Date: 2022-04-07